KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,241,000 | -21.3% | 830,472 | -29.3% | 0.27% | -16.0% |
| Q4 2021 | $15,547,000 | -58.8% | 1,175,131 | -45.7% | 0.33% | -55.8% |
| Q3 2021 | $37,754,000 | -27.2% | 2,163,554 | 0.0% | 0.74% | -20.0% |
| Q2 2021 | $51,839,000 | +97.8% | 2,163,554 | +112.1% | 0.92% | +67.2% |
| Q1 2021 | $26,204,000 | +153.6% | 1,020,005 | +14.5% | 0.55% | +30.9% |
| Q3 2019 | $10,332,000 | -61.7% | 890,668 | -26.9% | 0.42% | -56.6% |
| Q2 2019 | $26,971,000 | +45.0% | 1,217,668 | +87.3% | 0.97% | +35.9% |
| Q1 2019 | $18,603,000 | +44.9% | 650,000 | 0.0% | 0.71% | +38.7% |
| Q4 2018 | $12,838,000 | -10.7% | 650,000 | 0.0% | 0.51% | -0.2% |
| Q3 2018 | $14,372,000 | – | 650,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |